Infant Bacterial Therapeutics AB
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2021-03-29 | Infant Bacterial Therapeutics AB | Anders Kronström | Other senior executive | Acquisition | 3 500 | 100 | SEK | 350 000 | 2021-03-25 |
| 2021-05-05 | Infant Bacterial Therapeutics AB | Robert Molander | Member of the Board of Directors | Acquisition | 4 000 | 11,25 | USD | 45 000 | 2021-05-03 |
| 2021-05-06 | Infant Bacterial Therapeutics AB | Peter Rothschild | Member of the Board of Directors | Acquisition | 100 000 | 93,3 | SEK | 9 330 000 | 2021-05-03 |
| 2021-05-06 | Infant Bacterial Therapeutics AB | Staffan Strömberg | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 1 500 | 96,7 | SEK | 145 050 | 2021-05-03 |
| 2021-05-06 | Infant Bacterial Therapeutics AB | Anders Kronström | Other senior executive | Acquisition | 1 650 | 95,26 | SEK | 157 179 | 2021-05-03 |
| 2021-05-07 | Infant Bacterial Therapeutics AB | Kristina Sjöblom Nygren | Member of the Board of Directors | Acquisition | 100 | 91,9 | SEK | 9 190 | 2021-05-03 |
| 2021-06-29 | Infant Bacterial Therapeutics AB | Anthon Jahreskog | Member of the Board of Directors | Acquisition | 1 200 | 94,5 | SEK | 113 400 | 2021-06-28 |
| 2021-11-30 | Infant Bacterial Therapeutics AB | Robert Molander | Member of the Board of Directors | Acquisition | 5 500 | 7,7 | USD | 42 350 | 2021-11-29 |
| 2022-02-10 | Infant Bacterial Therapeutics AB | Anthon Jahreskog | Member of the Board of Directors | Acquisition | 350 | 59,4 | SEK | 20 790 | 2022-02-09 |
| 2022-02-10 | Infant Bacterial Therapeutics AB | Anthon Jahreskog | Member of the Board of Directors | Acquisition | 650 | 59,5 | SEK | 38 675 | 2022-02-09 |
| 2022-05-31 | Infant Bacterial Therapeutics AB | Anders Kronström | Other senior executive | Acquisition | 75 000 | 7 | SEK | 525 000 | 2022-05-29 |
| 2022-06-01 | Infant Bacterial Therapeutics AB | Robert Molander | Other member of the company's administrative, management or supervisory body | Acquisition | 20 000 | 7 | SEK | 140 000 | 2022-05-29 |
| 2022-06-03 | Infant Bacterial Therapeutics AB | Staffan Strömberg | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 120 000 | 7 | SEK | 840 000 | 2022-05-29 |
| 2022-11-21 | Infant Bacterial Therapeutics AB | Maria Ekdahl | Chief Financial Officer (CFO) | Acquisition | 250 | 63,2 | SEK | 15 800 | 2022-11-20 |
| 2023-05-23 | Infant Bacterial Therapeutics AB | Anthon Jahreskog | Member of the Board of Directors | Acquisition | 149 | 42,8 | SEK | 6 377,2 | 2023-05-22 |
| 2023-05-23 | Infant Bacterial Therapeutics AB | Anthon Jahreskog | Member of the Board of Directors | Acquisition | 851 | 43 | SEK | 36 593 | 2023-05-22 |
| 2023-05-23 | Infant Bacterial Therapeutics AB | Maria Ekdahl | Chief Financial Officer (CFO) | Acquisition | 25 000 | 3,29 | SEK | 82 250 | 2023-05-19 |
| 2023-05-23 | Infant Bacterial Therapeutics AB | Maria Ekdahl | Chief Financial Officer (CFO) | Acquisition | 709 | 43 | SEK | 30 487 | 2023-05-21 |
| 2023-05-23 | Infant Bacterial Therapeutics AB | Anders Kronström | Other senior executive | Acquisition | 25 000 | 3,29 | SEK | 82 250 | 2023-05-19 |
| 2023-05-23 | Infant Bacterial Therapeutics AB | Maria Ekdahl | Chief Financial Officer (CFO) | Acquisition | 465 | 43 | SEK | 19 995 | 2023-05-22 |